596 filings
Page 7 of 30
8-K
1u605mz6d158pis9
29 May 18
Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA
4:13pm
8-K
kp5ukkk
9 Feb 18
Results of Operations and Financial Condition
12:00am
8-K
n7ltoou
8 Feb 18
Regulation FD Disclosure
12:00am
8-K
w29qkcl22bp1 ztq
31 Jan 18
Elite Pharmaceuticals Reports Positive Topline Results from SequestOxâ„¢ Pilot Study
12:00am
8-K
m3wc9thq35
10 Jan 18
Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic
12:00am
8-K
dio934tfeinkvg4 rac
2 Jan 18
Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP
12:00am
8-K
4fqm gfr3fdypb6
19 Dec 17
Other Events
12:00am
8-K
idqmphibf8s
9 Nov 17
Results of Operations and Financial Condition
12:00am
CT ORDER
5kdhvhc
11 Oct 17
Confidential treatment order
12:00am
8-K
e4x5m6vb 26
7 Sep 17
Other Events
12:00am
8-K
fum8t0
9 Aug 17
Results of Operations and Financial Condition
12:00am
8-K
jabum2
28 Jul 17
Elite Announces Co-Development of Four Additional Products with SunGen Pharma
12:00am
CT ORDER
ehnevloev y2g
12 Jul 17
Confidential treatment order
12:00am
8-K
yf28 wo8dz
12 Jul 17
Elite Announces New Development and License Agreement with SunGen Pharma LLC
12:00am
8-K
f53khqe5
7 Jul 17
Regulation FD Disclosure
12:00am
8-K
5bq jvx7t
14 Jun 17
Results of Operations and Financial Condition
12:00am